Back to search

Switzerland· 68498001

Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.

A palonosetron product containing palonosetronum, registered in Switzerland by Labatec Pharma SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A04AA05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPalonosetron Labatec 0.25 mg/ 5 ml, s…ATCA04AA05REGISTER NO.68498001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Palonosetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 10 of them publish a price we can compare per daily dose

Palonosetron · ATC A04AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • Switzerland: $124.11 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Palonosetron · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$124.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
palonosetronum
Manufacturer
Labatec Pharma SA
Country
Switzerland (CH)
ATC code
A04AA05
ATC class
Palonosetron
Defined daily dose
0.5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680684980015
    Durchstf 5 ml
    CHF 60.75

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for palonosetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Palonosetron · interactions on record

490 records

  • 139 severe
  • 195 moderate
  • 3 minor
  • 153 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Palonosetron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palonosetron products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Palonosetron Kalceks
  • Belgium · Palonosetron Fresenius Kabi, Palonosetron Juta
  • Bulgaria · Ферант
  • Cyprus · Ferant, Injosetron
  • Czechia · Ferant, Palonosetron Fresenius Kabi
  • Germany · Palonosetron Beta, Palonosetron Fresenius Kabi
  • Denmark · Palonosetron Kalceks, Palonosetron Macure
  • Estonia · Ferant, Palonosetron Kalceks
  • Spain · Ferant, Palonosetrón Qilu
  • Finland · Palonosetron Fresenius Kabi, Palonosetron Macure
  • France · Palonosetron Kalceks, Palonosetron Reig Jofre
  • United Kingdom (Northern Ireland) · Palonosetron Fresenius Kabi, Palonosetron Hydrochloride Qilu Pharma Spain
  • Greece · Ferant, Injosetron
  • Croatia · Ferant, Palonozetron Kalceks
  • Hungary · Palonosetron Kalceks, Palonosetron Onkogen
  • Ireland · Palonosetron
  • Iceland · Aloxi, Palonosetron Accord
  • Italy · Palonosetron Dr. Reddy’s, Palonosetron Fresenius Kabi
  • Liechtenstein · Aloxi, Palonosetron Accord
  • Lithuania · Ferant
  • Latvia · Ferant, Palonosetron Kalceks
  • Malta · Ferant, Palonosetron Anfarm
  • Netherlands · Palonosetron Fresenius Kabi
  • Norway · Aloxi, Palonosetron Accord
  • Portugal · Ferant, Palanossetrom Fresenius Kabi
  • Romania · Ferant, Palonosetron Dr. Reddy’s
  • Sweden · Ferant, Palonosetron Fresenius Kabi
  • Slovenia · Ferant, Palonosetron Fresenius Kabi
  • Slovakia · Ferant, Palonosetron Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a18a256c-10e4-46d8-bb7e-8f4f0cd06d17
GET /v1/drugs/a18a256c-10e4-46d8-bb7e-8f4f0cd06d17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "palonosetronum 0.25 mg",
  "valid_from": "2022-11-01",
  "limitations": "[{\"description\":\"Stark emetogene Chemotherapie.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-11-01\"}]",
  "galenic_form": "Inj Lös 0.25 mg/5ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2022-11-01",
  "self_retention_pct": 10
}

See everything about palonosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.